Market Cap 945.90M
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 5,396,700
Avg Vol 4,369,448
Day's Range N/A - N/A
Shares Out 299.34M
Stochastic %K 28%
Beta 0.81
Analysts Strong Sell
Price Target $9.00

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
JennyRowes
JennyRowes Feb. 7 at 2:23 PM
$ABCL could this be the next Regeneron in the making? “AbCellera Biologics is increasingly being valued as a struggling biotech rather than a scaled antibody discovery platform with expanding clinical optionality. The progression of ABCL635 into Phase 2, combined with analyst confidence and upcoming financial disclosures, suggests that the market may be mispricing both execution capability and long-term growth potential. For investors seeking exposure to platform-driven biotech upside at a depressed valuation, ABCL offers a compelling risk-reward profile under $5.”
1 · Reply
PorkchopSquats
PorkchopSquats Feb. 7 at 1:44 PM
$ABCL Follow me for more would’ve/should’ve calls that I’m too much of a bitch to do myself.
0 · Reply
Samb2344
Samb2344 Feb. 7 at 12:16 AM
$ABCL any buys
0 · Reply
Odoji
Odoji Feb. 6 at 7:45 PM
$ABCL 💉
0 · Reply
LIVE_Trading
LIVE_Trading Feb. 6 at 6:42 PM
$ABCL watch here. Near to High.
0 · Reply
LIVE_Trading
LIVE_Trading Feb. 6 at 6:31 PM
Currently holding $ABCL $ABAT $AIRS $GDRX $$GERN
0 · Reply
LIVE_Trading
LIVE_Trading Feb. 6 at 6:15 PM
bought $ABCL $SPY
0 · Reply
NasdaqInsights
NasdaqInsights Feb. 6 at 5:11 PM
I think $FUBO has potential, but my long-term conviction is stronger in HIMS. Current allocation: • 49.4% $ASTS • 35.33% $HIMS • 9.65% $PRME • 5.62% $ABCL Sometimes it’s about cutting small losses and doubling down where you believe. 🫡
0 · Reply
tkstockpicker
tkstockpicker Feb. 6 at 4:40 PM
$ABCL Next 🎯 3.33
0 · Reply
DeMampCamp
DeMampCamp Feb. 6 at 3:54 PM
$ABCL Welcome back 3s, now fight like hell to protect it! Congratulations to anyone that picked up shares in the 2s, being completely transparent, I didn't pick up a single share, I need to see a new confirmed bottom before I do, been burned way too many times!
3 · Reply
Latest News on ABCL
AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 3 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 3 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 4 months ago

AbCellera Biologics: Entering Growth Phase After A Pause


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 5 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 9 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 9 months ago

AbCellera Reports Q1 2025 Business Results


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition


AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


JennyRowes
JennyRowes Feb. 7 at 2:23 PM
$ABCL could this be the next Regeneron in the making? “AbCellera Biologics is increasingly being valued as a struggling biotech rather than a scaled antibody discovery platform with expanding clinical optionality. The progression of ABCL635 into Phase 2, combined with analyst confidence and upcoming financial disclosures, suggests that the market may be mispricing both execution capability and long-term growth potential. For investors seeking exposure to platform-driven biotech upside at a depressed valuation, ABCL offers a compelling risk-reward profile under $5.”
1 · Reply
PorkchopSquats
PorkchopSquats Feb. 7 at 1:44 PM
$ABCL Follow me for more would’ve/should’ve calls that I’m too much of a bitch to do myself.
0 · Reply
Samb2344
Samb2344 Feb. 7 at 12:16 AM
$ABCL any buys
0 · Reply
Odoji
Odoji Feb. 6 at 7:45 PM
$ABCL 💉
0 · Reply
LIVE_Trading
LIVE_Trading Feb. 6 at 6:42 PM
$ABCL watch here. Near to High.
0 · Reply
LIVE_Trading
LIVE_Trading Feb. 6 at 6:31 PM
Currently holding $ABCL $ABAT $AIRS $GDRX $$GERN
0 · Reply
LIVE_Trading
LIVE_Trading Feb. 6 at 6:15 PM
bought $ABCL $SPY
0 · Reply
NasdaqInsights
NasdaqInsights Feb. 6 at 5:11 PM
I think $FUBO has potential, but my long-term conviction is stronger in HIMS. Current allocation: • 49.4% $ASTS • 35.33% $HIMS • 9.65% $PRME • 5.62% $ABCL Sometimes it’s about cutting small losses and doubling down where you believe. 🫡
0 · Reply
tkstockpicker
tkstockpicker Feb. 6 at 4:40 PM
$ABCL Next 🎯 3.33
0 · Reply
DeMampCamp
DeMampCamp Feb. 6 at 3:54 PM
$ABCL Welcome back 3s, now fight like hell to protect it! Congratulations to anyone that picked up shares in the 2s, being completely transparent, I didn't pick up a single share, I need to see a new confirmed bottom before I do, been burned way too many times!
3 · Reply
tkstockpicker
tkstockpicker Feb. 6 at 3:18 PM
$ABCL bought
0 · Reply
Brb579
Brb579 Feb. 6 at 1:58 PM
$ABCL its over bro.
0 · Reply
DeMampCamp
DeMampCamp Feb. 6 at 1:40 PM
$ABCL Be very careful here, we know how this ALWAYS dives at the open and I most certainly don't trust this overall green market this morning, I won't be surprised whatsoever to see investors taking immediate profits at the bell. It sure would be a great morale booster to get back into the 3s though! Happy Friday everyone!
0 · Reply
BioTechHealthX
BioTechHealthX Feb. 6 at 11:30 AM
$ABCL Despite trading at depressed levels, AbCellera Biologics continues to earn Buy ratings from analysts. This article explores why NASDAQ: ABCL’s platform, pipeline progress, and upcoming earnings could challenge the market’s pessimism.https://biotechhealthx.com/biotech-news/heres-why-wall-street-still-says-buy-even-as-abcellera-abcl-trades-like-a-penny-stock/
1 · Reply
Odoji
Odoji Feb. 6 at 11:22 AM
0 · Reply
BioTechHealthX
BioTechHealthX Feb. 6 at 10:53 AM
$DNA $AEMD $ABCL $SXTC $THAR Biotech stocks often surge on news tied to clinical progress and regulatory updates. Learn why breakthroughs in drug discovery, genetics, and AI are translating into rapid price action across the sector today. https://biotechhealthx.com/biotech-news/top-10-biotech-stocks-with-the-biggest-price-gains-today/
0 · Reply
Odoji
Odoji Feb. 6 at 10:29 AM
$ABCL 💉
1 · Reply
Plutten1973
Plutten1973 Feb. 6 at 5:07 AM
$ABCL Amazing i hoped we was finish with this but not ok ok the case is still the same Patience !
0 · Reply
extremejd
extremejd Feb. 6 at 12:35 AM
$ABCL luckily i sold most of abcl in the 3’s and 4’s. i couldnt take the risk with this pos stock. it always goes down. lost most of its big gains
0 · Reply
mAbMaster
mAbMaster Feb. 5 at 9:43 PM
$ABCL Bought 6k shares today. Hard to resist a fire sale. If it keeps dropping, I'll keep buying. Easy decision when it's trading this low.
1 · Reply
Odoji
Odoji Feb. 5 at 8:55 PM
$ABCL 💉
1 · Reply
Ckkung71
Ckkung71 Feb. 5 at 8:39 PM
$ABCL Better it goes 2 $ now so we can refill.
1 · Reply